JP Morgan Private Wealth Advisors’s Nymox Pharmaceutical Corp NYMX Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-10,000	Closed	-$44K	–	1147
2014 Q3	$44K	Hold	10,000	–	–	﹤0.01%	1063
2014 Q2	$50K	Hold	10,000	–	–	﹤0.01%	877
2014 Q1	$55K	Hold	10,000	–	–	﹤0.01%	863
2013 Q4	$61K	Hold	10,000	–	–	﹤0.01%	645
2013 Q3	$66K	Hold	10,000	–	–	﹤0.01%	628
2013 Q2	$52K	Buy	+10,000	New	+$50.7K	﹤0.01%	610

Other funds holding NYMX

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return

AIG

American International Group New York $2.93M AUM 12.08% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BAS

Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

JP Morgan Private Wealth Advisors's NYMX Position: Q4 2014 in Review

JP Morgan Private Wealth Advisors sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2014, closing a stake of 10,000 shares — an estimated $44K sold.

JP Morgan Private Wealth Advisors first reported a position in NYMX in Q2 2013 and held it in 6 quarters. The position peaked at $66K in Q3 2013. 25 funds tracked by Wall St. Rank hold NYMX as of Q4 2014.

JP Morgan Private Wealth Advisors reported no remaining Nymox Pharmaceutical Corp position as of Q4 2014 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 10,000 Nymox Pharmaceutical Corp shares in Q4 2014, an estimated $44K.
JP Morgan Private Wealth Advisors first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 6 quarters.
JP Morgan Private Wealth Advisors's Nymox Pharmaceutical Corp position peaked at $66K in Q3 2013.
25 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2014.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2014, filed 11 Feb 2015.